|
State Medicaid offices are targeting the homes of deceased individuals to recoup healthcare costs, leading to legal battles and emotional distress for families. While this practice varies widely among states, some lawmakers and advocates argue that it perpetuates wealth disparities and intergenerational poverty, calling for reforms to make the recovery process optional rather than mandatory.
|
New data reveals that marriage rates surged in 2022 after a dip during the Covid-19 lockdowns, reaching 6.2 marriages per 1,000 people. Lockdowns forced couples to confront relationship issues, leading to more intentional partnerships and potentially contributing to the decline in divorce rates, which fell to 2.4 per 1,000 people in 2022. This trend reflects a shift towards "companionate marriages," where partners prioritize qualities conducive to long-term stability and satisfaction.
|
Senator Bernie Sanders has introduced a bill to shorten the standard workweek in the US from 40 hours to 32 hours, arguing that advancements in technology allow for more leisure time without compromising pay and benefits. While proponents cite studies showing increased job satisfaction and stable or improved revenues in some companies with a 32-hour workweek, critics warn of potential productivity losses, especially in industries requiring hands-on labor. Despite historical roots in labor movements advocating for shorter workdays, bipartisan support for such legislation remains uncertain in the current political climate.
|
The introduction of zuranolone, a promising treatment for postpartum depression, has raised questions about how insurers will handle coverage for this novel and costly medication. While zuranolone offers potential benefits for patients, including fast-acting relief, most private health insurers have yet to establish coverage criteria, leaving patients and providers uncertain about accessibility. Concerns persist based on past restrictions, highlighting the need for transparent and equitable access to novel mental health treatments .
|
The over-the-counter availability of Narcan, designed to address opioid overdoses, faces challenges in accessibility and visibility in stores across the U.S., potentially limiting its impact amidst the ongoing opioid crisis. While sales of the drug have increased, concerns persist regarding pricing, stigma, and inconsistent availability, suggesting a need for broader education and accessibility initiatives.
|
|